BMJ Case Rep
Dr. Tara M. Balija, MD
- Medicare services, 2024
- 40
- Medicare patients, 2024
- 48
- Part D claims, 2024
- 12
- Publications
- 7
- Clinical trials
- 2
- Practice address
- 787 11th Ave, New York, NY 10019
- Practice phone
- Call (475) 477-5188
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
787 Ortho ASC LLC
New York, New York
Find Dr. Balija's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Tara M. Balija is a surgical oncologist in New York, New York
Dr. Balija practices at 787 Ortho ASC LLC in New York, New York.
Dr. Balija's NPI, 1518284579, was assigned on April 29, 2010. Dr. Balija graduated from Icahn School Of Medicine At Mount Sinai in 2008. Dr. Balija's New York license number on file is 316133.
- NPI
- 1518284579NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9638491699
- NPI enumeration date
- April 29, 2010
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (475) 477-5188
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 44
- Medical school graduation
- 2008
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Tara M. Balija practices at 787 Ortho ASC LLC in New York, New York
Dr. Balija's primary practice is 787 Ortho ASC LLC, at 787 11th Ave, New York, NY 10019 in New York County. The practice phone is (475) 477-5188.
- 787 Ortho ASC LLC787 11th Ave, New York, NY 10019 · New York CountyPhone(475) 477-5188
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Tara M. Balija is affiliated with 3 sites of care and 1 medical group
Dr. Balija's primary practice is 787 Ortho ASC LLC in New York, New York. Dr. Balija is also affiliated with Mount Sinai West. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Balija to 1 more group practice or clinic, named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Tara M. Balija's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balija practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| 787 Ortho ASC LLC | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Tara M. Balija is one of 162 surgical oncologists in New York
Surgical oncology is Dr. Balija's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Balija is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Balija's licenses on file in 2 states: New York and New Jersey.
Specialties and state licenses
- Surgical oncology, New YorkPrimary
- Surgery, New Jersey
Clinical focus
Dmand AI lists mastectomy among the conditions Dr. Balija treats.
Surgical oncologists near Dr. Balija
Counts of surgical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Tara M. Balija billed Medicare for 40 services in 2024
CMS data shows 40 Medicare services from Dr. Balija across 2 procedure codes in 2024, all of them office visits, for 48 Medicare patients. Medicare paid $4,412 for them. Every service was in an office.
Dr. Balija's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 322024: 4025%
Dr. Balija compared with the New York median for surgical oncologists, 2024
- Dr. Balija
- New York median
- Medicare services
- 40vs 12468% below
- Medicare patients
- 48vs 9650% below
- Part D claims
- 13vs 1513% below
Medians across 145 surgical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Balija's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Balija?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Balija and other surgical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Tara M. Balija treated 48 Medicare patients in 2024, average age 73
CMS counts 48 Medicare patients who saw Dr. Balija in 2024. The largest group is 65 to 74, with 20 patients. 63% of them have cancer, and 63% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Balija's median patient age at 48, with 96% women.
Dr. Balija's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Balija's Medicare patients, 2024
- Cancer63%
- High cholesterol63%
- High blood pressure54%
- Arthritis48%
- Anxiety27%
- Diabetes25%
- Osteoporosis25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Balija's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 48
Patient panel by sex, all payers
- Women96%
- Men1%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Tara M. Balija wrote 12 Medicare Part D claims in 2024
In 2024, Dr. Balija wrote 12 Medicare Part D claims. 92% of them were for generic drugs. They cover 1 drug, with $66 in total drug cost. In 2019, CMS named 26 claims across 2 drugs.
Dr. Balija's Part D claims by kind of drug, 2024
- Generic11 claims92%
- Brand-name and other1 claims8%
Dr. Balija's most prescribed drugs by claims, 2020
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2019 to 2020
- 2019
- 2020
- Claims for drugs CMS names
- 2019: 262020: 1350%
Drugs named by CMS: 1 in 2020, 2 in 2019.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Tara M. Balija takes part in Medicare
Dr. Balija accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)
Sources: Doctors and Clinicians National Downloadable File (CMS); and Doctors and Clinicians Utilization Data (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Tara M. Balija has 7 publications on record
Dmand AI links 7 papers to Dr. Balija, published from 2012 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Breast Neoplasms and Breast. Dr. Balija has published most often in BMJ Case Rep. Dr. Balija's most frequent co-authors are Stephanie F. Bernik, MD, Marnie Abeshouse and Harry L. Anderson, MD.
Dr. Balija's papers by year, 2012 to 2024
Topics Dr. Balija writes about most
- Breast Neoplasms
- Breast
Dr. Balija's most frequent co-authors
- Stephanie F. Bernik, MD3 shared papers
- Marnie Abeshouse1 shared paper
- Harry L. Anderson, MD1 shared paper
Recent publications by Dr. Balija
J Am Coll Surg
See who Dr. Balija researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Balija works with, so you can find a warm path to the right surgical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Tara M. Balija has worked on 2 clinical trials
Dmand AI links Dr. Balija to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Ductal and Breast Diseases.
Conditions in Dr. Balija's trials
- Breast Neoplasms
- Carcinoma, Ductal
- Breast Diseases
- Carcinoma, Intraductal, Noninfiltrating
Investigators on the most trials with Dr. Balija
Recent clinical trials with Dr. Balija
Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS (opens in a new tab)
Comparison of Axillary Lymph Node Dissection with Axillary Radiation for Patients with Node-Positive Breast Cancer Treated with Chemotherapy (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Tara M. Balija received $578 in industry payments from 2021 to 2025
CMS Open Payments shows 9 general payments to Dr. Balija from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 61% of the total. KUB Technologies Inc. paid the most, $511.
General payments to Dr. Balija by program year, 2021 to 2025
General payments to Dr. Balija by kind, 2021 to 2025
- Food and beverage$35461%
- Entertainment$22439%
Companies that paid Dr. Balija the most, 2021 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Tara M. Balija has 1 award and honors on record
Dmand AI lists 1 award for Dr. Balija, most recently Graduation with Distinction in Research in 2008.
Awards and honors for Dr. Balija
- 2008
- Graduation with Distinction in Research
Source: Dmand AI Professional Profile Data
Dr. Tara M. Balija graduated from Icahn School Of Medicine At Mount Sinai
Dr. Balija graduated from Icahn School Of Medicine At Mount Sinai in 2008. Dr. Balija is a member of ACS, ASBS, New York Metropolitan Breast Cancer Group and SSO.
- Medical school
- Board certified in surgery
Source: Dmand AI Professional Profile Data
Dr. Tara M. Balija accepts plans from 18 insurance carriers
Dr. Balija is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
- Aetna
- Excellus BlueCross BlueShield
- Elevance
- Horizon Blue Cross Blue Shield of New Jersey
- United Healthcare
- HCSC
- Aspirus Health Plan
- Blue Cross Blue Shield of Massachusetts
- +10 more carriersWith a free account
Plan types Dr. Balija accepts, by number of carriers
- PPO12
- Medicare11
- HMO9
- POS6
- EPO4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Tara M. Balija's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Tara M. Balija
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Tara M. Balija's NPI number?
Dr. Tara M. Balija's NPI number is 1518284579. It was assigned on April 29, 2010, and it is active in the NPI Registry.
What kind of doctor is Dr. Tara M. Balija?
Dr. Tara M. Balija is a surgical oncologist in New York, New York. The primary specialty in the NPI Registry is Surgical Oncology Physician (taxonomy code 2086X0206X).
Where does Dr. Tara M. Balija practice?
Dr. Balija practices at 787 11th Ave, New York, NY 10019. Dr. Balija's primary practice is 787 Ortho ASC LLC in New York, New York. Dmand AI also links Dr. Balija to 1 group practice or clinic.
What is Dr. Tara M. Balija's office phone number?
The practice phone on file for Dr. Balija is (475) 477-5188.
What is Dr. Tara M. Balija's medical license number?
Dr. Balija's New York license number on file is 316133, one of the licenses on file in 2 states.
Which states has Dr. Tara M. Balija been licensed in?
Dmand AI has state licenses on file for Dr. Balija in New York (2022 to 2025) and New Jersey (2012 to 2023).
Which hospitals is Dr. Tara M. Balija affiliated with?
Dr. Balija is affiliated with Mount Sinai West.
What medical group is Dr. Tara M. Balija part of?
Dr. Balija is linked to Mount Sinai Institute for Liver Medicine.
Does Dr. Tara M. Balija accept Medicare?
Yes. CMS data shows Dr. Balija billed Medicare for 40 services in 2024, and Dr. Balija accepts Medicare assignment.
How many Medicare patients does Dr. Tara M. Balija see?
CMS counts 48 Medicare patients who saw Dr. Balija in 2024, with an average age of 73.
Show 9 more questionsShow fewer questions
Is Dr. Tara M. Balija board certified?
Yes. Dr. Balija is board certified in surgery by the American Board of Surgery.
What services does Dr. Tara M. Balija bill to Medicare?
In 2024, Dr. Balija's most billed Medicare services were office visit, established patient (99214) and office visit, new patient (99204).
Where did Dr. Tara M. Balija go to medical school?
Dr. Balija graduated from Icahn School Of Medicine At Mount Sinai in 2008.
What drugs does Dr. Tara M. Balija prescribe most?
In 2020 Medicare Part D data, Dr. Balija's most prescribed drugs by claims were Sulfamethoxazole-Trimethoprim.
Has Dr. Tara M. Balija received payments from drug or device companies?
CMS Open Payments shows $578 in general payments to Dr. Balija from 3 companies from 2021 to 2025. The largest total came from KUB Technologies Inc.
How long has Dr. Tara M. Balija been practicing?
Dr. Balija graduated from medical school in 2008, 18 years ago.
Does Dr. Tara M. Balija do research?
Dmand AI links 7 publications to Dr. Balija, published from 2012 to 2024. Dr. Balija has worked on 2 clinical trials.
Who does Dr. Tara M. Balija publish with?
Dr. Balija's most frequent co-authors are Stephanie F. Bernik, MD (3 shared papers), Marnie Abeshouse (1 shared paper) and Harry L. Anderson, MD (1 shared paper).
What insurance does Dr. Tara M. Balija accept?
Dr. Balija is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.
Selling to surgical oncology practices?
See surgical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card